Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from Evgen Pharma ( (GB:TCF) ) is now available.
Theracryf PLC, a UK-based company, has announced a change in its major holdings, as Oberon Investments Limited has acquired or disposed of voting rights, crossing a significant threshold on March 11, 2025. This notification, completed on March 21, 2025, indicates Oberon now holds 3.779% of the voting rights, totaling 80,475,000 shares, which may impact the company’s governance and stakeholder influence.
More about Evgen Pharma
YTD Price Performance: -56.73%
Average Trading Volume: 3,792,212
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £4.79M
Learn more about TCF stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue